14-day Premium Trial Subscription Try For FreeGet Free
NASDAQ:INFI

Infinity Pharmaceuticals Stock Price (Quote)

NASDAQ Stock Exchange > Healthcare > Biotechnology
Open Broker Account
$0.0160
+0 (+0%)
At Close: Dec 04, 2023
Chart & Forecast Earnings Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.0160 $0.0160 Monday, 4th Dec 2023 INFI stock ended at $0.0160. During the day the stock fluctuated 0% from a day low at $0.0160 to a day high of $0.0160.
90 days $0.0111 $0.100
52 weeks $0.0111 $0.770

Historical Infinity Pharmaceuticals prices

Date Open High Low Close Volume
2023-12-04 $0.0160 $0.0160 $0.0160 $0.0160 0
2023-12-01 $0.0160 $0.0160 $0.0160 $0.0160 0
2023-11-30 $0.0160 $0.0160 $0.0160 $0.0160 0
2023-11-29 $0.0160 $0.0160 $0.0160 $0.0160 0
2023-11-28 $0.0160 $0.0160 $0.0160 $0.0160 0
2023-11-27 $0.0160 $0.0160 $0.0160 $0.0160 0
2023-11-24 $0.0160 $0.0160 $0.0160 $0.0160 0
2023-11-22 $0.0160 $0.0160 $0.0160 $0.0160 0
2023-11-21 $0.0160 $0.0160 $0.0160 $0.0160 0
2023-11-20 $0.0160 $0.0160 $0.0160 $0.0160 0
2023-11-17 $0.0160 $0.0160 $0.0160 $0.0160 0
2023-11-16 $0.0160 $0.0160 $0.0160 $0.0160 0
2023-11-15 $0.0160 $0.0160 $0.0160 $0.0160 0
2023-11-14 $0.0160 $0.0160 $0.0160 $0.0160 0
2023-11-13 $0.0160 $0.0160 $0.0160 $0.0160 0
2023-11-10 $0.0160 $0.0160 $0.0160 $0.0160 0
2023-11-09 $0.0160 $0.0160 $0.0160 $0.0160 0
2023-11-08 $0.0160 $0.0160 $0.0160 $0.0160 0
2023-11-07 $0.0160 $0.0160 $0.0160 $0.0160 0
2023-11-06 $0.0160 $0.0160 $0.0160 $0.0160 0
2023-11-03 $0.0160 $0.0160 $0.0160 $0.0160 0
2023-11-02 $0.0160 $0.0160 $0.0160 $0.0160 0
2023-11-01 $0.0160 $0.0160 $0.0160 $0.0160 0
2023-10-31 $0.0160 $0.0160 $0.0160 $0.0160 0
2023-10-30 $0.0160 $0.0160 $0.0160 $0.0160 0
Click to get the best stock tips daily for free!

About Infinity Pharmaceuticals

Infinity Pharmaceuticals Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of metastatic triple negative breast cancer and urothelial cancer; and Phase 1/1b clinical trials for the tre... INFI Profile

Golden Star

Ticker Date Change Price
ENS Nov 30 3.54% $88.48
THS Nov 30 3.07% $40.71
ESS Nov 30 4.36% $213.46
KMX Nov 30 6.79% $63.94
CVNA Nov 30 27.94% $31.32
ATKR Nov 30 2.53% $129.90
ADP Nov 30 1.16% $229.92
PAGP Nov 29 1.63% $15.92
AMRC Nov 29 14.18% $28.34
CP Nov 29 4.60% $71.32
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT